Companies/Panacos Pharmaceuticals, Inc.

Company profile

Panacos Pharmaceuticals, Inc.

OTC: PANC · Healthcare · Biotechnology

PublicHQ Watertown, Reports USD

#998 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ —GM —SS 46

v0.1 · 5/100 weight · pillars only

↑ operating margin, listing tenure · ↓ Piotroski F, net margin

Methodology →

Revenue TTM

$99.0k

Rev growth YoY (TTM)

-45.9%

Net income (FY)

-$37.5M

Employees

Market cap

$5.4k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$180.0k$180.0k2007

Net income-$37.5M-$37.5M2007

Operating income$39.0M$39.0M2007

Total assets$55.7M$55.7M2007

Liabilities$26.8M$26.8M2007

Equity$28.9M$28.9M2007

Revenue trend

FY2000 – FY2007 · USD

$40.7M

FY00

$26.9M

FY01

$4.2M

FY02

$1.1M

FY03

$1.3M

FY04

$1.0M

FY05

$284.0k

FY06

$180.0k

FY07

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Panacos Pharmaceuticals, Inc. booked $180.0k in FY2007 revenue, contracting 37% year over year — slower than 78% of Healthcare companies we track, at a -20810.6% net margin.

Peers · Healthcare

Radient Technologies Inc.——LadRx Corporation——Better Therapeutics, Inc.——Bangi Inc.——

Key facts

CEOJohn R. Barr

SectorHealthcare

IndustryBiotechnology

HeadquartersWatertown, null

ExchangeOTC: PANC

Employees41

IPO date2005-03-14

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.